Navigation Links
BioRestorative Therapies, Inc. Begins Trading Under New Name and Symbol ("BRTX")
Date:9/19/2011

JUPITER, Fla., Sept. 19, 2011 /PRNewswire/ -- BioRestorative Therapies, Inc. (OTCQB: BRTX) (the "Company"), formerly known as Stem Cell Assurance, Inc., today announced that its common stock is now trading on the OTCQB market under its new name, BioRestorative Therapies, Inc., and that the trading symbol for its common stock has been changed from "SCLZ" to "BRTX."

Mark Weinreb, the Company's Chairman and Chief Executive Officer, said, "The commencement of trading using our new symbol and name is one more positive step in positioning BRT as an emerging player in the stem cell arena. This helps signal the beginning of our branding of the Company and the initiatives we are pursuing."

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc.'s goal is to become a medical center of excellence using cell and tissue protocols, primarily involving a patient's own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. In June 2011, the Company launched a platform technology that involves the use of a brown fat cell-based therapeutic/aesthetic program, known as the ThermoStem Program.  The ThermoStem program will focus on treatments for obesity, weight loss, diabetes, hypertension, other metabolic disorders and cardiac deficiencies and will involve the study of stem cells, several genes, proteins and/or mechanisms that are related to these diseases and disorders.  As more and more cellular therapies become standard of care, the Company believes its strength will be its focus on the unity of medical and scientific explanations for clinical procedures and outcomes for future personal medical applications.  The Company also plans to offer and sell facial creams and products under the Stem Pearls™ brand.

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including those set forth in the Company's Form 10, as amended, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.

CONTACT:
Mark Weinreb
CEO
Tel: (561) 904-6070
Fax: (561) 429-5684


'/>"/>
SOURCE BioRestorative Therapies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioRestorative Therapies, Inc. Announces Upgrade to OTCQB Market
2. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
3. Course correction needed for Alzheimers therapies, experts warn
4. As New Data Wave Begins, a Gene Study in One Disease Discovers Mutations in an Unrelated Disease
5. Austen BioInnovation Institute in Akron Begins Work on Roadmap for First U.S. Accountable Care Community
6. Vaxart Begins First Oral Vaccine Clinical Trial
7. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
8. Tissue Genesis Begins FDA-Approved Clinical Trial
9. Wind tunnel begins operations at Empa in Duebendorf
10. Biotech Begins Year on a Quiet, but Optimistic Note
11. USDA scientists discover how foot-and-mouth disease virus begins infection in cattle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... to their offering. ... The study scope includes key agricultural biotechnology ... biology tools and genome editing tools); synthetic biology-enabled chemicals and ... products are analyzed to determine present and future market sizes, ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today that ... enhance training plan management for consistent implementation of standards and regulatory requirements across ... Group to help improve and streamline their training and employee development programs, which ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... at a Marketing Roundtable on March 22 in Philadelphia. The event was offered ... , The Marketing Roundtable featured breakout groups and interaction with speakers ...
(Date:3/28/2017)... Summary This report provides all the information ... interests and activities since 2010. Description The Partnering Deals ... the partnering activity of one of the world,s leading life ... upon purchase to ensure inclusion of the most up to ... be delivered in PDF format within 1 working day of ...
Breaking Biology Technology:
(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/9/2017)... Australia , March 9, 2017 4Dx ... prestigious World Lung Imaging Workshop at the University of ... was invited to deliver the latest data to world ... recognised event brings together leaders at the forefront of ... in lung imaging. "The quality of ...
(Date:3/7/2017)... 2017   HireVue , the leading provider of ... the best talent, faster, today announced the additions of ... and Diana Kucer as Chief Marketing Officer ... team poised to drive continued growth in the company,s ... of record bookings in 2017. "Companies worldwide ...
Breaking Biology News(10 mins):